Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.46), $0.07 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $127.3 million versus the consensus estimate of $128.75 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.